Clinical trial
A Multi-Center, Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI)
NCT02820350 is registered in ClinicalTrials.gov with CytoPherx, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI)
- Lead sponsor
- CytoPherx, Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 4, 2016
- Completion date
- March 31, 2020
- Enrollment
- 19 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.